معرفی
Simon Lykkeboe serves as a Researcher within the Department of Clinical Biochemistry at Aalborg University Hospital, under the Faculty of Medicine of Aalborg University. His academic focus centers on clinical biochemistry applications in endocrinology and bone metabolism, with particular emphasis on diabetes-bone health interactions and laboratory diagnostics optimization.
His primary research interests include Bone Turnover (100% fingerprint match), Type 1 Diabetes (42-55% match), Bone Density (48% match), and Clinical Laboratory Medicine. He investigates osteocalcin dynamics in diabetic populations, preanalytical stability challenges, and analytical interference in monoclonal gammopathy diagnostics, bridging laboratory science with clinical endocrinology.
Analysis of his 2022-2025 publications reveals three dominant trends: (1) bone health complications in type 1 diabetes using cross-sectional designs, (2) optimization of preanalytical protocols for analyte stability during sample transport, and (3) resolution of immunoglobulin measurement interference in hematological disorders. His work consistently leverages large Danish patient cohorts and interdisciplinary collaboration.
Dr. Lykkeboe contributed as Co-Investigator to the "Big data" research project (2015-2022) focused on clinical biochemistry diagnostics enhancement. He maintains active collaborations with Vestergaard, Handberg, and Andersen groups across bone metabolism, thyroid disorders, and lymphoma treatment studies.
Within Aalborg University Hospital's Department of Clinical Biochemistry, he operates in a multidisciplinary environment integrating laboratory diagnostics with clinical research, supporting the hospital's mission to advance precision medicine through rigorous biochemical analysis and data-driven insights.
